The main indicators of the WHO Global Monitoring Framework (GMF) on Noncommunicable Diseases
|
|
- Clemence Fields
- 5 years ago
- Views:
Transcription
1 The main indicators of the WHO Global Monitoring Framework (GMF) on Noncommunicable Diseases 2016 In the spotlight diabetes, target indicators
2 Preface Noncommunicable diseases (NCD) are major public health threats in the European Region with effects extending beyond health, impacting economic and societal development. Four major groups of NCD, cardiovascular diseases, cancer, diabetes and chronic respiratory diseases, are responsible for the largest share of disease burden, including premature and avoidable death, morbidity and disability. These NCD also share common risk factors, e.g. tobacco use, harmful alcohol consumption, unhealthy diet, physical inactivity and obesity, making them a target for health promotion, prevention and control. The NCD are considered strategic priorities for action of the World Health Organization (WHO) and its Member States, as reflected in the 2012 Global Action Plan for the prevention and control of Noncommunicable Diseases and its Global Monitoring Framework, with nine voluntary targets and twenty-five indicators. Additionally, in 2014 the United Nations (UN) General Assembly proposed strengthening progress on the implementation of high-impact cost-effective interventions on NCD and setting four time-bound commitments, including defined indicators. Further recognizing NCD relevance, in 2015 the UN proposed the inclusion of a specific health target with NCD indicators in the Sustainable Development Goals , while considering involvement of other healthrelated ones in the monitoring framework. Moreover, at the European regional level, the Health 2020 policy framework includes 6 targets and 21 core health indicators, among which are several NCDrelated ones. The above mandates highlight the need for improved availability, quality and timeliness of country information to allow monitoring progress on such targets. A requisite for planning and evaluation for NCD prevention and control is the assessment of data on disease situation and trends, their risk factors and the response of the health system. Assembling and analyzing such information demands comprehensive integration of data from many sources, a challenge in some countries. The WHO Regional Office for Europe, through its NCD Project Office in Moscow, is supporting Member States to improve their capacity to present and interpret their NCD data in a manner suitable for policy-making. When required, assistance is also provided for strengthening data availability through survey implementation, disease registries functioning and compilation of other relevant information, to achieving Health 2020 and the time-bound UN NCD review of Furthermore, the Regional Office is monitoring current conditions and changes on NCD in its Member States, as well as progress towards global and regional targets. This is done jointly with other WHO technical units, for example, through collaboration in the European Health Information Gateway, where multiple European health databases and other related information resources are compiled in the Web. We are pleased to present The main indicators of the WHO Global Monitoring Framework (GMF) on Noncommunicable Diseases 2016, which exemplifies the joint effort of WHO and its Member States to offer recently available, comparable and policy-relevant NCD information. This set of data and graphs come from diverse WHO sources and altogether provide an account of the status and progress of key indicators, highlighted in colour, in countries of the European Region. Also, selected diabetes-related indicators are presented in a section to showcase the relevance of this special topic in the Region. We expect that this publication will become a useful tool for policy-makers, public health professionals and other interested users. Gauden Galea Director
3 Noncommunicable diseases targets: demographic and mortality indicators Mid-year population (thousands) All causes mortality, both sexes Proportion of all deaths due to (%) cancer Age-standardized death rates per population Major noncommunicable diseases (cardiovascular disease, cancer, diabetes, or chronic respiratory disease), (30 69 years), diseases of circulatory system Both Males Females Country Albania Andorra Armenia a 20.7 a 47.6 a c a c a c a a a a a Azerbaijan c 9.3 c 58.6 c c c c Belarus b 13.9 b 50.2 b c b c b c b a 28.0 a 25.8 a b b b Bosnia and Herzegovina b 19.5 b 53.2 b b b b b 16.7 b 63.5 b b b b a 23.1 a 35.9 a a a a a 31.8 a 23.3 a a a a b 24.5 b 48.6 b a a a a a a b 32.7 b 22.1 b b b b a a a a 27.6 a 39.3 a a a a Iceland c 30.7 c 34.1 c c c c c c c a 31.1 a 31.3 a c c c c c c Israel a a a a 32.2 a 32.9 a b b b a 12.2 a 30.7 a a a a Kyrgyzstan a 21.4 a 51.7 a a a a a 20.4 a 50.5 a a a a a a a Malta b b b Monaco Montenegro c 15.2 c 54.6 c c c c c c c a a a a a a a a a a a a a 20.2 a 56.4 a a a a b 15.3 b 54.1 b b b b San Marino c 44.2 c 40.1 c c c c c 23.1 c 51.8 c c c c c c c c 32.7 c 36.4 c c c c c c c a a a a a a Switzerland c c c c c c Tajikistan c 7.7 c 59.6 c MKD* c 18.3 c 58.9 c c c c c c c Turkmenistan a 15.0 a 61.3 a a a a b 31.7 b 27.1 b c c c c c c c 6.7 c 65.6 c c c c WHO European Region a 20.8 a 45.3 a a a a Note: a = 2012, b = 2011, c =
4 Noncommunicable diseases targets: mortality indicators Probability (%) of dying between ages 30 and 70 from cancer, diabetes, cardiovascular or chronic respiratory disease, both sexes Diseases of circulatory system, Age-standardized death rates per population Ischaemic heart disease, Cerebrovascular diseases, Males Females Males Females Males Females Diseases of the respiratory system, both sexes Diabetes, both sexes Country Albania Andorra Armenia a a a a 98.5 a 82.2 a 53.8 a 41.5 a Azerbaijan c c c 93.2 c c c 55.9 c 13.8 c Belarus b b b b b b 27.6 b 2.5 b a a 63.8 a 26.1 a 35.0 a 29.7 a 53.0 a 8.3 a Bosnia and Herzegovina b b 93.5 b 54.8 b b 97.2 b 27.7 b 40.2 b b b b 73.5 b a a 36.1 b 13.2 b a a 92.5 a 34.6 a 36.3 a 34.5 a 38.5 a 32.8 a a a 64.2 a 31.7 a 39.3 a 30.4 a 59.2 a 14.6 a b b b b 73.5 b 45.1 b 21.7 b 8.1 b b 81.0 b 45.0 b 16.4 b 28.7 b 20.8 b 26.3 b 9.1 b a a 92.3 a 35.3 a 68.2 a 62.0 a 47.3 a 5.6 a Iceland c c c 54.6 c 42.7 c 31.8 c 42.4 c 7.6 c b b a 58.4 a 34.2 a 33.2 a 61.7 a 9.7 a Israel a a 75.2 a 37.7 a 44.9 a 37.5 a 29.4 a 15.8 a a a a 81.4 a a 95.9 a 79.7 a 9.9 a Kyrgyzstan a a a a a a 24.0 a 14.2 a a a a a a 92.8 a 27.3 a 6.9 a Malta Monaco Montenegro c c 83.5 c 39.7 c 66.6 c 74.8 c 38.7 c 11.2 c a a a a a a 49.4 a 7.9 a b b b b b b 44.7 b 5.2 b San Marino c c 30.9 c 8.3 c 58.9 c 49.4 c 6.9 c 4.5 c c c c c c 76.9 c 52.0 c 10.3 c c c 94.9 c 40.5 c 71.2 c 49.1 c 32.3 c 7.8 c Switzerland Tajikistan c c c c c 94.4 c 78.8 c 23.3 c MKD* c c c 57.1 c c c 34.4 c 34.1 c Turkmenistan a a a a a a 29.0 a 4.0 a b b b 44.4 b b 5.4 b c c c c c c 66.4 c 30.2 c WHO European Region a a a a 99.4 a 77.0 a 45.0 a 12.9 a Note: a = 2012, b = 2011, c =
5 Noncommunicable diseases targets: cancer indicators Age-standardised rates per population Incidence, Mortality, All cancers Lung Colorectum Breast Cervix uteri Lung Colorectum Breast Cervix uteri Both Both Both Females Females Both Both Females Females Country Albania Andorra Armenia a 14.1 a 32.7 a 5.5 a b Azerbaijan c 3.8 c 7.6 c 2.1 a Belarus b 19.3 b 18.1 b 5.4 b a a 16.4 a 25.4 a 2.3 a Bosnia and Herzegovina b 17.4 b 17.8 b 4.5 a b 20.1 b 22.2 b 7.3 a a b a 12.0 a 19.6 a 1.3 a b a 21.9 a 25.9 a 2.7 a b b 20.4 b 22.6 b 7.4 b a a b 16.1 b 22.5 b 1.8 b c a 12.9 a 20.7 a 1.9 a Iceland a c 17.1 c 20.1 c 1.4 c a a 19.2 a 26.6 a 4.0 a Israel a a 16.8 a 21.7 a 0.9 a a 13.6 a 19.7 a 9.1 a Kyrgyzstan a 23.3 a 22.6 a 8.5 a a a 19.1 a 22.3 a 9.0 a b Malta Monaco Montenegro c 11.4 c 20.4 c 3.5 c a a c a 20.5 a 21.2 a 12.0 a b 22.0 b 23.3 b 6.9 b San Marino b c 19.4 c 16.7 c 0.0 c a c c 28.0 c 22.0 c 6.3 c b c 25.6 c 24.7 c 3.0 c Switzerland b Tajikistan 36.7 a c 3.0 c 7.2 c 2.9 c MKD* c c 17.5 c 27.7 c 2.8 c c Turkmenistan a 21.0 a 24.0 a 7.5 a a b 16.3 b 24.6 b 2.4 b c 3.9 c 11.6 c 5.7 c WHO European Region a a 17.4 a 20.6 a 4.2 a Note: a = 2012, b = 2011, c =
6 Risk factors: alcohol and tobacco Recorded alcohol per capita (15 years & over) consumption (litres of pure alcohol), 3-year average, total Heavy episodic drinking (population 15 years & over) past 30 days, (%), total** years old heavy episodic drinkers (population), (%), total Alcohol use disorders (15 years & over), 12 month prevalence (%), total** Prevalence current smoking any tobacco product, (%), ** Both Males Females Price of 20-cigarette pack of most sold brand (Intn'l. dollars at PPP) Specific excise tax as a % of price of most sold brands Country Albania Andorra Armenia Azerbaijan Belarus Bosnia and Herzegovina Iceland Israel Kyrgyzstan Malta Monaco Montenegro San Marino Switzerland Tajikistan MKD* Turkmenistan Regional average ** Age-standardized figures
7 Risk factors: blood pressure, cholesterol and immunization Prevalence, percent of population with raised blood pressure (SBP 140 or DBP 90), (18 years and over), (age-standardized estimate), Prevalence, percent of population with total cholesterol 190 mg/dl (5.0 mmol/l), (25 years and over), (age-standardized estimate), Immunization coverage, 1-year-olds, Hepatitis B, both sexes, (%) Both Males Females Both Males Females Country Albania Andorra Armenia Azerbaijan Belarus Bosnia and Herzegovina Iceland Israel Kyrgyzstan Malta Monaco Montenegro San Marino Switzerland Tajikistan MKD* Turkmenistan WHO European Region
8 Diabetes and related risk factors: glucose, overweight and obesity, physical activity, policy There is a policy, strategy, or action plan for diabetes Age-standardized death rates per population Proportion of all discharges (%) Diabetes, Hospital discharges,average length of stay, (in days) Total number of discharges from all causes (thousands) Prevalence, percent population with fasting glucose 126 mg/dl (7.0 mmol/l) or on medication for raised blood glucose, (18 years and over),, (%)** Prevalence, percent of population with body mass index (BMI) of 25 kg/m 2 or higher, (18 years and over), (age-standardized estimate), Prevalence of overweight (including obesity), (%) Prevalence of insufficient physical activity among school going adolescents (crude estimate), (%) Prevalence of insufficient physical activity among adults (age-standardized estimate), (%) 13 years old years 18 years and over Males Females Males Females Males Females Males Females Males Females Males Females Boys Girls Boys Girls Males Females Country Albania Andorra Armenia a 45.4 a a 0.9 a 11.4 a 10.9 a 1057 a 1221 a Azerbaijan c 15.5 c Belarus b 2.3 b a 7.2 a 1.2 c 0.9 c 9.1 c 9.6 c 836 c 1005 c *** 9.5*** Bosnia and Herzegovina b 41.7 b b 12.0 b a 27.7 a 0.4 a 0.2 a 8.4 a 5.7 a 35 a 35 a a 0.9 a 12.8 a 14.3 a 940 a 1168 a a 10.2 a 1.1 c 0.7 c 6.6 c 6.1 c 413 c 488 c b 7.6 b a 0.7 a 9.4 a 12.7 a 431 a 530 a b 6.8 b 1.2 a 1.0 a 6.7 a 6.8 a 5018 a 5952 a a 0.9 a 12.4 a 11.1 a 9499 a a a 4.4 a a 1.6 a 8.3 a 9.3 a 862 a 1142 a Iceland 9.4 c 5.7 c 0.6 c 0.4 c 10.8 c 10.3 c 19 c 26 c a 7.4 a 1.4 a 0.7 a 8.7 a 7.8 a 253 a 372 a Israel c 0.4 c 6.1 c 6.3 c 562 c 715 c a 13.7 a 0.6 a 0.4 a 8.7 a 9.0 a 3582 a 4086 a a 10.6 a Kyrgyzstan a 12.7 a 0.8 a 0.7 a 6.8 a 7.5 a 155 a 199 a a 5.9 a 1.0 a 1.0 a 8.5 a 8.5 a 313 a 402 a a 0.8 a 9.1 a 10.0 a 34 a 41 a Malta a 0.7 a 15.0 a 15.0 a 30 a 33 a Monaco Montenegro c 11.4 c a 0.5 a 7.9 a 7.5 a 906 a 1082 a c 0.5 c 4.3 c 4.2 c 397 c 460 c a 1.1 a 8.2 a 8.0 a 2810 a 3440 a a 7.1 a 1.5 a 1.4 a 6.9 a 6.9 a 2017 a 2415 a b 5.6 b San Marino c 3.6 c a 2.6 a 0.1 a 0.1 a 442 a 536 a c 9.4 c 1.1 b 0.9 b 8.9 b 9.3 b 423 b 568 b c 6.5 c 0.7 a 0.5 a 8.9 a 7.3 a 157 a 195 a a 0.5 a 8.7 a 8.0 a 2182 a 2489 a c 0.8 c 6.7 c 6.5 c 690 c 834 c Switzerland a 0.3 a 10.9 a 9.7 a 614 a 716 a Tajikistan c 22.4 c MKD* c 35.7 c 1.7 c 1.8 c 12.4 c 11.3 c 96 c 107 c b 1.7 b 6.6 b 5.9 b 4976 b 6461 b Turkmenistan a 3.8 a b 0.5 b 8.0 b 7.2 b 3616 b 4807 b **** 34.0**** c 30.7 c WHO European Region a 11.9 a ** Age-standardized figures *** The average between Flanders and Wallonia **** The average between England, Scotland and Wales Note: a = 2012, b = 2011, c =
9 Noncommunicable diseases: quantitative and qualitative indicators Incidence and mortality from malignant neoplasm of lungs, both sexes, European Region, Incidence and mortality from malignant neoplasm of breast, females, European Region, Montenegro MKD* Armenia Iceland Belarus Bosnia and Herzegovina Switzerland Azerbaijan Israel Malta Kyrgyzstan Tajikistan Mortality Incidence Armenia MKD* Israel Malta Montenegro Iceland Switzerland Belarus Bosnia and Herzegovina Kyrgyzstan Azerbaijan Tajikistan Mortality Incidence Age-standardised rates per Age-standardised rates per Raised blood pressure (sbp 140 OR dbp 90) prevalence difference between 2010 and 2014,, European Region Fasting glucose 126 mg/dl (7.0 mmol/l) prevalence difference between 2010 and 2014,, European Region Iceland Andorra Israel Malta Switzerland Belarus Montenegro MKD* Armenia Albania Azerbaijan Bosnia and Herzegovina Turkmenistan Tajikistan Females Males Turkmenistan Tajikistan Azerbaijan Kyrgyzstan Switzerland Andorra Armenia Belarus Israel MKD* Montenegro Albania Iceland Bosnia and Herzegovina Females Males Prevalence (%) Prevalence (%)
10 Noncommunicable diseases: quantitative and qualitative indicators Body mass index (bmi) of 30 kg/m 2 or higher prevalence difference between 2010 and 2014,, European Region Females Males Prevalence (%) Prevalence of insufficient physical activity among adults, 18 years+,, 2010, European Region Kyrgyzstan Bosnia and Herzegovina Andorra Malta Montenegro MKD* Israel Andorra Malta Armenia Iceland Switzerland Albania Belarus Kyrgyzstan Tajikistan Turkmenistan Azerbaijan Females Males Prevalence (%) Percentage of countries having a policy, strategy or action plan for ncd, European Region, Saturated fatty acids Marketing of foods Unhealthy diet WHO, Regional Office for Europe Overweight/obesity Physical inactivity Tobacco use Harmful use of alcohol Diabetes Chronic respiratory diseases Cancer Cardiovascular diseases 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
11 Technical notes The WHO Global Monitoring Framework (GMF) on Noncommunicable Diseases (NCD) includes 9 voluntary targets for prevention and control by 2025 and 25 indicators for monitor progress. To facilitate identification, GMF indicators are marked in a colour, while those on diabetes mellitus (the special topic), are coloured differently. Mortality from major NCD and cancer incidence (indicators 5, 12) are based on WHO European Mortality and Health for All databases ( and Probability of dying (indicator 6) shows the percentage of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes or chronic respiratory disease and was calculated using cause-specific mortality rates in standard life table methods. Recorded alcohol per capita consumption (indicator 21) is defined as the recorded amount of alcohol consumed per capita (15+ years) over a calendar year in a country, in litres of pure alcohol. Heavy episodic drinking (indicators 22 23) is defined as the proportion of adults (15+ years) who have had at least 60 grams or more of pure alcohol on at least one occasion in the past 30 days. Prevalence of current smoking of any tobacco product (indicator 25) by persons aged 15 years and above, resulting from analysis of the full set of adult tobacco use surveys. Prevalence of raised blood pressure (indicator 28) is a percent of defined population with raised blood pressure (systolic blood pressure 140 OR diastolic blood pressure 90). Prevalence of raised total cholesterol (indicator 29) is a percent of defined population with total cholesterol 190 mg/dl (5.0 mmol/l). Immunization coverage (indicator 30) is the percentage of oneyear-olds who have received three doses of hepatitis B vaccine in a given year. Prevalence of raised fasting blood glucose (indicator 36) is a percent of defined population with fasting glucose 126 mg/dl (7.0 mmol/l) or on medication for raised blood glucose. Prevalence of overweight, Body Mass Index 25 (indicator 37) is a percentage of defined population with a body mass index (BMI) of 25 kg/m 2 or higher. For detailed definition of other indicators of the GMF and others used here, see the following documents/ links: Indicator Source of data 1 European Health for All database (HFA-DB) 2,5, 7 12, 32, , 21 25, 28 30, 36 37, 39, 40 European mortality database (MDB) Global Health Observatory (GHO) 38 European Database on Nutrition, Obesity and Physical Activity (NOPA) 31 Noncommunicable Diseases Progress Monitor ncd-progress-monitor-2015/en/ GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in European hospital morbidity database (HMDB) european-hospital-morbidity-database-hmdb WHO Report on the Global Tobacco Epidemic, 2015 Raising taxes on tobacco World Health Organization, 2016 All rights reserved. The European Regional office of the World Health Organization willing to satisfy requests to reproduce or translate its publications, in part or in full. The designations used in this publication and in cited materials do not reflect any opinions of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. World Health Organization, Regional Office for Europe UN City, Marmovej 51, DK-2100 Copenhagen, Phone: Fax: contact@euro.who.int Web:
National Strategic Action Plan for Prevention and control of NCDs ( ) Myanmar. April 2017
National Strategic Action Plan for Prevention and control of NCDs (2017-2021) NOT APPROVED Myanmar April 2017 1 5. Financial protection is provided to individuals and families suffering from selected NCDs.
More informationNoncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?
Noncommunicable diseases progress monitoring Are we meeting the time-bound United Nations targets? Background paper for the WHO European Meeting of National NCD Directors and Programme Managers, Moscow,
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationEuropean status report on alcohol and health Leadership, awareness and commitment
European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential
More informationMonitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators
Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators
More informationEuropean Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
More informationNational Strategy. for Control and Prevention of Non - communicable Diseases in Kingdom of Bahrain
Kingdom of Bahrain Ministry of Health National Strategy for Control and Prevention of Non - communicable Diseases in Kingdom of Bahrain 2014 2025 Behavioural Risk Factors Tobacco Use Unhealthy Diets Physical
More informationWHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej
More informationWHO Secretariat Dr Timothy Armstrong Coordinator, Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion
WHO Secretariat Dr Timothy Armstrong Coordinator, Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion Overview: Revised WHO Discussion Paper (A/NCD/INF./1)
More informationRECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for
More informationNutrition, diet and health in the WHO European Region Progress and opportunities for further action to achieve SDGs by 2030
Nutrition, diet and health in the WHO European Region Progress and opportunities for further action to achieve SDGs by 2030 João Breda Head, WHO European Office for Prevention and Control of Noncommunicable
More informationSecond presentation: Ms Leanne Riley Team Leader Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion
Second presentation: Ms Leanne Riley Team Leader Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion World Health Organization Targets presented in the first
More informationThe cancer burden in the European Union and the European Region: the current situation and a way forward
The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers
More informationHealth Strategies for NCD prevention and Control
Health Strategies for NCD prevention and Control International Symposium on Research, Policy & Action to Reduce the Burden of Non-Communicable Diseases Faculty of Medicine, Gadjah Mada University, Yogyakarta,
More informationBetter Health for All in Latvia
Better Health for All in Latvia The health strategy for the European Region (Health 2020) and the Latvian Public Health Strategy 2011 2017 Zsuzsanna Jakab WHO Regional Director for Europe 18 April 2011,
More informationNCDs and H2020. The Big Shift. Gauden Galea Paris, June 2012
NCDs and H2020 The Big Shift Gauden Galea Paris, June 2012 Health 2020 Inequity Governance Whole of society Public health capacity Address Inequity 80 Life expectancy at birth, in years Address the social
More informationPriorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region
Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region Zsuzsanna Jakab WHO Regional Director for Europe A big challenge Globally every year 7.6 million children die
More informationDiabetes. Halt the diabetes epidemic
Diabetes Halt the diabetes epidemic WHO Library Cataloguing in Publication Data World Health Organization. Regional Office for the Eastern Mediterranean Diabetes: halt the diabetes epidemic / World Health
More informationRole of UN Agencies in Achieving the Sustainable Development Goals (SDG 3.4)
Role of UN Agencies in Achieving the Sustainable Development Goals (SDG 3.4) Oyere K. Onuma, MD MSc Medical Officer, Cardiovascular Diseases Management of Noncommunicable Diseases, Disability, Violence
More informationGlobal NCD Prevention WHO Strategies and Implementation Plan. Dr Ruitai Shao Chronic Disease and Health Promotion
Global NCD Prevention WHO Strategies and Implementation Plan Dr Ruitai Shao Chronic Disease and Health Promotion Outline Main NCDs and Major risk factors Global Action Plan for implementing the strategy
More informationHighlighting in the WHO European Region: Summary. No. 21(February 2012)
No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationGlobal overview of Non- Communicable Diseases (NCDs)
Faculty of Medicine الصحة العامة (31505291) Health Public Lecture 15 Global overview of Non- Communicable Diseases (NCDs) By Hatim Jaber MD MPH JBCM PhD 25-7-2018 1 1. The global health impact of mental
More informationRisk Factors for NCDs
Risk Factors for NCDs Objectives: Define selected risk factors such as; tobacco use, diet, nutrition, physical activity, obesity, and overweight Present the epidemiology and significance of the risk factors
More informationOverview of the Global NCD Action Plan
Regional Consultation to Develop the Strategic Action Plan and Targets for Prevention and Control of Noncommunicable Diseases in the SEAR 25-27 February 2013 Overview of the Global NCD Action Plan 2013-2020
More information2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE
2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE Massimo F Piepoli, MD, PhD, FESC, Piacenza, Italy on behalf of the 6 th Joint Task Force 2 3 Guidelines still based upon the principles of
More informationHarmful Use of Alcohol A Global Public Health Perspective
GLOBAL ALCOHOL POLICY CONFERENCE COEX Congress Centre, Seoul, Republic of Korea, 7 October 2013 Harmful Use of Alcohol A Global Public Health Perspective Mr Dag Rekve Department of Mental Health and Substance
More informationWhere is WHO heading? Which interactions of research agenda and policy?
Where is WHO heading? Which interactions of research agenda and policy? V. Poznyak, MD, PhD Coordinator, Management of Substance Abuse Department of Mental Health and Substance Abuse e WHO strategy on
More informationHighlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance
No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella
More informationA report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%
% of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected
More informationLessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH
Lessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH Director Division of Information, Evidence, Research and Innovation WHO Regional Office for
More informationAlcohol and Public Health: burden and global response. Maristela G Monteiro, MD PhD Senior Advisor on Alcohol and Substance Abuse
.. Alcohol and Public Health: burden and global response Maristela G Monteiro, MD PhD Senior Advisor on Alcohol and Substance Abuse Currently used model for alcohol and health outcomes Societal factors
More informationNoncommunicable Diseases Global Monitoring Framework: Indicator Definitions and Specifications
Noncommunicable Diseases Global Monitoring Framework: Indicator s and Specifications Introduction Global monitoring framework Global targets for NCDs Setting national targets Reporting on the global NCD
More informationWHO Health Statistics : Applied through the lens of the Global Monitoring Framework for the Prevention and Control of Noncommunicable Diseases
WHO Health Statistics : Applied through the lens of the Global Monitoring Framework for the Prevention and Control of Noncommunicable Diseases Dr E Tursan d'espaignet Prevention of Noncommunicable Diseases
More informationProf. Jean-Marie DANGOU, WHO/AFRO, Brazzaville (Congo)
THE BURDEN OF NCDs Taking a quantum leap Prof. Jean-Marie DANGOU, WHO/AFRO, Brazzaville (Congo) FAMSA General Assembly, Ibadan, Nigeria 19 November 2018 THE WORLD S BIGGEST KILLER Non-communicable diseases
More informationWORLD HEALTH ORGANIZATION
SDG target 3.4: By 2030, reduce by one third premature mortality from NCDs through prevention and treatment and promote mental health and well-being Where do we stand today? What progress has been made
More informationBudapest, Hungary, September 2017 xx July xxx. Progress reports
Regional Committee for Europe 67th session EUR/RC67/xx Budapest, Hungary, 11 14 September 2017 xx July 2017 170xxx Provisional agenda item 5(h) ORIGINAL: ENGLISH Progress reports This document contains
More informationNATIONAL STRATEGIC ACTION PLAN FOR THE PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASESs (RAN PP-PTM) Draft- version 4 August, 2016
NOT APPROVED NATIONAL STRATEGIC ACTION PLAN FOR THE PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASESs (RAN PP-PTM) 2016-2019 Draft- version 4 August, 2016 DIRECTORATE GENERAL OF DISEASE CONTROL AND ENVIRONMENTAL
More informationGlobal Strategies to Improve Cancer Care and Control
Women s Empowerment Cancer Advocacy Network (WE CAN) Conference Global Strategies to Improve Cancer Care and Control Tbilisi, Georgia October 15-16, 2013 Julie R. Gralow, M.D. Jill Bennett Endowed Professor
More informationCombatting noncommunicable diseases global burden and best practices
Combatting noncommunicable diseases global burden and best practices Renu Garg, MD, MPH Medical Officer Noncommunicable Diseases WHO Thailand Outline Global burden Strategies for NCD prevention and control
More informationBurden and cost of alcohol, tobacco and illegal drugs globally and in Europe
Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationSurveillance and Chronic Disease Policies and Interventions: WHO European Region. Dr Jill Farrington Coordinator, Noncommunicable Diseases
Surveillance and Chronic Disease Policies and Interventions: WHO European Region Dr Jill Farrington Coordinator, Noncommunicable Diseases Overview European NCD Strategy Risk factor surveillance in Europe
More informationNoncommunicable Diseases Global Monitoring Framework: Indicator Definitions and Specifications
Noncommunicable Diseases Global Monitoring Framework: Indicator s and Specifications Introduction Global monitoring framework Global targets for NCDs Setting national targets Reporting on the global NCD
More informationPreventing disease Promoting and protecting health
Preventing disease Promoting and protecting health NCD Surveillance in the Caribbean: Preparing for Reporting on Regional and Global NCD indicators Dr. Glennis Andall-Brereton Acting Head, NCDs and Life
More informationSituation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.
Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. WHO/Europe publishes a weekly electronic bulletin on influenza activity in the Region 1 and
More informationWHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States
WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States 8 10 September 2014 Hammamet, Tunisia MEETING REPORT WHO MEETING ON STRENGTHENING
More informationÝÐ Ë ÌÝÍÄÈÉÍ ßÀÌ THE SECOND NATIONAL PROGRAM ON PREVENTION AND CONTROL OF DISEASES CAUSED BY UNHEALTHY LIFESTYLES
ÝÐ Ë ÌÝÍÄÈÉÍ ßÀÌ THE SECOND NATIONAL PROGRAM ON PREVENTION AND CONTROL OF DISEASES CAUSED BY UNHEALTHY LIFESTYLES Ulaanbaatar, 2014 THE SECOND NATIONAL PROGRAM ON PREVENTION AND CONTROL OF DISEASES CAUSED
More informationEffective actions to reduce the harmful use of alcohol
Effective actions to reduce the harmful use of alcohol Dag Rekve, Senior Technical Officer, World Health Organization Dag Rekve Senior Technical Officer WHO HQ/NMH Switzerland www.who.int/substance_abuse/en/
More informationWHO methodology. Alcohol consumption
Alcohol consumption WHO methodology Dr Alexandra Fleischmann, Mr Dag Rekve and Dr Vladimir Poznyak Management of Substance Abuse Unit (MSB) Department of Mental Health and Substance Abuse, WHO, Geneva
More informationSocioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women
Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women (Lancet. 2017 Mar 25;389(10075):1229-1237) 1 Silvia STRINGHINI Senior
More informationMulti-Sectoral responses to Non- Communicable Diseases
Transforming Health in the African Region Multi-Sectoral responses to Non- Communicable Diseases www.afro.who.int THE WORLD S BIGGEST KILLER Non-communicable diseases (NCDs) leading cause of death in the
More informationEURO POLIO PAGE Data as of 04 October 2005 (Week 38)
World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:
More informationThe Millennium Development Goals & Post 2015 Opportunities and Challenges
The Strengthening Health Systems, Supporting NCD Action Advocating for Policies and Action Meeting November 22, 2013, Port of Spain, Trinidad and Tobago The Millennium Development Goals & Post 2015 Opportunities
More informationPLAN OF MONITORING NCD AND THE PROGRESS IN THEIR CONTROL IN ALBANIA FRAMEWORK OF INDICATORS AND THEIR METADATA
PLAN OF MONITORING NCD AND THE PROGRESS IN THEIR CONTROL IN ALBANIA FRAMEWORK OF INDICATORS AND THEIR METADATA Summary in English Tirana May 2015 1 Alban Ylli Genc Burazeri Ervin Toci Sonela Xinxo Enver
More informationThe challenge of obesity in the WHO European Region
Fact sheet EURO/13/05 Copenhagen, Bucharest, 12 September 2005 The challenge of obesity in the WHO European Region Obesity poses one of the greatest public health challenges for the 21st century, with
More informationWHO Framework Convention on Tobacco Control
WHO Framework Convention on Tobacco Control When WHO was established in 1948, its Member States incorporated the power to negotiate treaties into its Constitution. This power remained dormant until 1996,
More informationInequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest
More informationReflecting on ten years of progress in the fight against AIDS, TB and malaria
Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:
More informationInequality in injury risks
Inequality in injury risks Rationale Injuries a are a neglected but preventable epidemic and in the 53 countries in the WHO European Region account for nearly 800 000 lives lost annually (equivalent to
More informationAlcohol consumption, harm and policy responses in Europe. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe
Alcohol consumption, harm and policy responses in Europe Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Burden of NCD in Europe Burden of disease by broad cause group
More informationHighlighting in the WHO European Region:
No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationMedia centre Obesity and overweight
1 of 5 06/05/2016 4:54 PM Media centre Obesity and overweight Fact sheet N 311 Updated January 2015 Key facts Worldwide obesity has more than doubled since 1980. In 2014, more than 1.9 billion adults,
More informationSummary. Primary care data. Week 49/2014. Season
Summary Week 49/2014 In week 49/2014, influenza activity remained low across the WHO European Region. Twenty countries reported sporadic influenza activity and nine reported increasing trends in consultations
More informationTechnical consultation on reducing sugar intake in the Eastern Mediterranean Region
Summary report on the Technical consultation on reducing sugar intake in the Eastern Mediterranean Region WHO-EM/NUT/270/E Amman, Jordan 26 27 July 2015 Summary report on the Technical consultation on
More informationCardiovascular disease in Europe: epidemiological update 2016
European Heart Journal (2016) 37, 3232 3245 doi:101093/eurheartj/ehw334 REVIEW Cardiovascular disease in Europe: epidemiological update 2016 Nick Townsend 1 *, Lauren Wilson 1, Prachi Bhatnagar 1, Kremlin
More informationAnalysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage
A MONTHLY NEWSLETTER OF THE COMMUNICABLE DISEASE UNIT, WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE, COPENHAGEN, DENMARK Issue 5, March 2009 Analysis of 3-dose oral/inactivated poliovirus vaccine
More informationALCOHOL S BURDEN (with special attention to Africa and the NCDs)
ALCOHOL S BURDEN (with special attention to Africa and the NCDs) Isidore S. Obot, PhD, MPH Professor of Psychology, University of Uyo Director, Centre for Research and Information on Substance Abuse (CRISA),
More information1Health Improvement Card. User guide for health professionals
World Health Professions Alliance WHPA 1Health Improvement Card User guide for health professionals World Health Professions Alliance WHPA C/o World Medical Association BP 63 01210 Ferney Voltaire France
More informationWHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive
WHO/NMH/TFI/11.3 WHO REPORT on the global TOBACCO epidemic, 2011 Warning about the dangers of tobacco Executive summary fresh and alive World Health Organization 2011 All rights reserved. Publications
More informationIndicator 3.a.1: Age-standardized prevalence of current tobacco use among persons aged 15 years and older
Goal 3: Ensure healthy lives and promote well-being for all at all ages Target 3.a: Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries,
More informationHepatitis C in the WHO European Region
Hepatitis C in the WHO European Region Antons Mozalevskis WHO Regional Office for Europe Drug-related infectious disease (DRID) annual expert meeting 15 16 June 2015, EMCDDA Lisbon Burden of viral hepatitis
More informationNoncommunicable Diseases in the Western Pacific Region. A Profile
Noncommunicable Diseases in the Western Pacific Region A Profile Noncommunicable Diseases in the Western Pacific Region A Profile WHO Library Cataloguing in Publication Data Noncommunicable diseases in
More informationNational response to harmful use of alcohol. A presentation By Dr. Sheila Ndyanabangi Principal Medical Officer In charge- Alcohol Control Programme
National response to harmful use of alcohol A presentation By Dr. Sheila Ndyanabangi Principal Medical Officer In charge- Alcohol Control Programme Introduction Alcohol is widely used in all societies
More informationInjuries in Europe: a call for public health action An update from 2008 WHO Global Burden of Disease
Key facts Injuries in Europe: a call for public health action An update from 2008 WHO Global Burden of Disease There were 664 000 deaths from unintentional and intentional They are the leading cause of
More informationThe number of new cases is expected to rise by about 70% over the next 2 decades.
World Health Organization Cancer Fact sheet February 2017 Key facts Cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012 1. The number
More informationNCD Burden in the South-East Asia Region Regional Action Plan and Targets. Dr. Renu Garg Regional Advisor NCD
NCD Burden in the South-East Asia Region Regional Action Plan and Targets Dr. Renu Garg Regional Advisor NCD 1.8 Billion People 25% of world s population Outline of presentation Burden of NCDs Regional
More informationNational Multi-sectoral Action Plan for Prevention & Control of NCDs in India
National Multi-sectoral Action Plan for Prevention & Control of NCDs in India Webinar on Double-Duty Policies for Improved Nutrition 7 th June 2017 Prof. Damodar Bachani, MD, MPHM Deputy Commissioner (NCD)
More informationManuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal
Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging
More informationHealth Literacy for NCD prevention, management and prompting equality
Health Literacy for NCD prevention, management and prompting equality How to use health literacy to improve understanding and responses to NCDs? WHO Global Coordination Mechanism on NCDs Working Group
More informationRegional NCD Strategy,
Pan American Health Organization Regional NCD Strategy, 2013-2020 C James Hospedales, Senior Advisor & Coordinator, NCD Prevention & Control PAHO/WHO Pan American Forum for Action on NCD May 9, 2012, Brasilia
More informationMedia Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences
Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of
More informationOverall Assessment: Good level of support for target although there were some concerns on achievability.
(Version dated 22 March 2012) SUMMARY OF FEEDBACK FROM MEMBER STATES ON THE FIRST DISCUSSION PAPER ON THE PROPOSED GLOBAL MONITORING FRAMEWORK AND INDICATORS AND TARGETS FOR THE PREVENTION AND CONTROL
More informationCancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/32 Provisional agenda item 15.6 13 April 2017 Cancer prevention and control in the context of an integrated approach Report by the Secretariat 1. In January 2017, the
More informationSOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES
SOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES We, the participants in the South African Summit on the Prevention and Control of Non- Communicable diseases gathered
More informationThe Global Tobacco Problem
Best Practices in Tobacco Control Policy: An Update Johanna Birckmayer, PhD, MPH Campaign for Tobacco Free Kids The Global Tobacco Problem Almost one billion men and 250 million women are daily smokers
More informationNCD and Mental Health. Oleg Chestnov ADG/NMH Gauden Galea DNP
NCD and Mental Health Oleg Chestnov ADG/NMH Gauden Galea DNP Global Process World Health Assembly resolution WHA64.11 REQUESTS THE DIRECTOR-GENERAL TO: (4) to report to the Sixty-fifth World Health Assembly,
More informationAchieving the United Nations 2030 Sustainable Development Goals, Health 2020 and the SEE 2020 goals: how to make it happen?
Achieving the United Nations 2030 Sustainable Development Goals, Health 2020 and the SEE 2020 goals: how to make it happen? Dr Zsuzsanna Jakab WHO Regional Director for Europe 1 A changing world A rapidly
More informationProgress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium
More informationKyrgyz Republic: Tobacco Facts. Source: Richard Peto etc Mortality from smoking in developed countries,
Kyrgyz Republic: Tobacco Facts 1. Tobacco is one of only two major causes of death worldwide that are still increasing: the other is infection with human immunodeficiency virus HIV-AIDS. At current smoking
More informationThe local healthcare system: Focusing on health
The local healthcare system: Focusing on health Sian Griffiths Professor of Public Health Director of the School of Public Health Chairman, Department of Community and Family Medicine The Chinese University
More informationAnimal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)
Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous) 25 th Conference of the OIE Regional Commission for Europe 17 th to 21 st September 2012, Fleesensee Germany
More informationNon communicable Diseases in Egypt and North Africa
Non communicable Diseases in Egypt and North Africa Diaa Marzouk Prof. Community Medicine Faculty of Medicine, Ain Shams University Egypt 11 th March 2012 Level of Income North African countries according
More informationManagement of Non-communicable Diseases - Prevention Vs. Intervention
Editorial Healthline Journal Volume 8 Issue 2 (July-December 2017) Management of Non-communicable Diseases - Prevention Vs. Intervention 1 2 D. S. Martolia, Tanu Midha 1 2 Professor and Head, Associate
More informationThe National perspective Public Health England s vision, mission and priorities
The National perspective Public Health England s vision, mission and priorities Dr Ann Hoskins Director Children, Young People and Families Public Health England May 2013 Mission Public Health England
More informationThe DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN
1. INTRODUCTION The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN 2014 2018 UNITE AGAINST DIABETES STOP RISING TREND Diabetes is a significant and growing challenge globally that affects individuals,
More informationProgress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States
Progress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States Vilma Q. Tyler UNICEF CEE/CIS Regional Nutrition Specialist Ankara, 12-15 June, 2012 Factors Impacting
More informationRegional framework for action on cancer prevention and control Executive summary
Regional Committee for the Eastern Mediterranean Sixty-fourth session Provisional agenda item 3(a) EM/RC64/3 September 2017 Regional framework for action on cancer prevention and control Executive summary
More informationIntroducing. the WHO Regional Office for Europe
Introducing the WHO Regional Office for Europe Foreword Today, people in the WHO European Region enjoy better health than ever before. Advances in science and technology have created unprecedented opportunities
More informationSOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES
SOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES We, the participants in the South African Summit on the Prevention and Control of Non- Communicable diseases gathered
More information55th DIRECTING COUNCIL
55th DIRECTING COUNCIL 68th SESSION OF THE REGIONAL COMMITTEE OF WHO FOR THE AMERICAS Washington, D.C., USA, 26-30 September 2016 Provisional Agenda Item 7.12-C CD55/INF/12 1 July 2016 Original: English
More information